Hamayak Sisakian

Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: Results from an international multicentre retrospective cohort study

Gabriele Fragasso, Giuseppe Rosano, Sang Hong Baek et al. · International Journal of Cardiology · 2012 · 96 citations · Full text

Cardiovascular Toxicity, Metabolic Syndrome, Heart Failure +10

Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure

Claudia Marini, Gabriele Fragasso, Leonardo Italia et al. · Heart · 2020 · 80 citations

Takotsubo syndrome is a coronary microvascular disease: experimental evidence

Feng Dong, Liya Yin, Hamayak Sisakian et al. · European Heart Journal · 2023 · 65 citations · Full text

Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma

Daniel J. Luther, Vahagn Ohanyan, Patricia E. Shamhart et al. · Investigational New Drugs · 2009 · 40 citations

Oncology, Hepatology, Chemopreventive Doses +10

The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy

Hamayak Sisakian, Adrina Torgomyan, Anush Barkhudaryan · Acta Cardiologica · 2007 · 32 citations